Albatati, Sawsan
Sharma, Atul
Haubrich, Kathryn
Wright, Alissa
Gantt, Soren
Blydt-Hansen, Tom D.
Article History
Received: 23 January 2019
Revised: 15 May 2019
Accepted: 16 July 2019
First Online: 4 August 2019
Competing interests
: S.G. receives research funding and consulting fees from Merck, GSK, VBI, and Meridian Biosciences. T.D.B.-H. receives research funding from Astellas. A.W. has received consulting fees or honoraria from Merck, AVIR Pharma, Pendopharm, and Astellas. A.S. has received payment for “conducting or overseeing statistical analyses.” The other authors declare no competing interests.